Efficacy and safety of favipiravir plus interferon-beta versus lopinavir/ritonavir plus interferon-beta in moderately ill patients with COVID-19: A randomized clinical trial
法匹拉韦联合干扰素β与洛匹那韦/利托那韦联合干扰素β治疗中度COVID-19患者的疗效和安全性：一项随机临床试验
期刊:Journal of Medical Virology
影响因子:4.6
doi:10.1002/jmv.27724
Hassaniazad, Mehdi; Farshidi, Hossein; Gharibzadeh, Abdollah; Bazram, Ali; Khalili, Elham; Noormandi, Afsaneh; Fathalipour, Mohammad
